← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2004Last known activity
Dec 31, 2025
Timeline
2000s
- Jun 1, 2002
Fundació Sant Joan de Déu— Founded
Drugs by trial phase (28 distinct, 20 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Aspergillosis
- Fetal Growth Retardation
- Glioma
- Invasive Pulmonary Aspergillosis
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Multiple Organ Failure
- Neoplasm, Residual
- Neuroblastoma
- Obesity
- Overweight
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Aspergillosis
- Retinoblastoma
- Schizophrenia
- Scoliosis
- Weight Loss
Recent trials (21)
- NCT07243678Lead sponsorN/ADec 31, 2025
- NCT05394142Lead sponsorPhase 2May 24, 2022
- NCT04739995Lead sponsorPhase 4Jan 1, 2022
- NCT04739995Overall official - principal investigatorPhase 4Jan 1, 2022
- NCT05038462CollaboratorN/ASep 30, 2021
- NCT04633044Lead sponsorPhase 1/Phase 2Dec 31, 2020
- NCT06438614Lead sponsorPhase 2Aug 20, 2020
- NCT04646447Lead sponsorN/AJul 30, 2020
- NCT03324139Lead sponsorPhase 3Oct 31, 2017
- NCT03284268Lead sponsorEarly Phase 1Sep 6, 2017
- NCT02840123Lead sponsorPhase 1Jun 1, 2016
- NCT02169609Lead sponsorPhase 2Nov 1, 2015
- NCT02571491Lead sponsorPhase 2Jan 1, 2012
- NCT02612259Lead sponsorPhase 2Jan 1, 2012
- NCT01615809Lead sponsorPhase 2Oct 1, 2011
Details
- Founded
- Barcelona, ES Jun 1, 2002
- Last known activity
- Dec 31, 2025